| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | proteoglycan binding | 2.19e-07 | 51 | 21 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | calcium ion binding | 4.98e-07 | 749 | 21 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 3.60e-06 | 29 | 21 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.02e-05 | 188 | 21 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 4.36e-05 | 192 | 21 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | Roundabout binding | 6.91e-05 | 12 | 21 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | collagen binding | 8.11e-05 | 81 | 21 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.25e-04 | 16 | 21 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.59e-04 | 268 | 21 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.19e-04 | 21 | 21 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.24e-04 | 323 | 21 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | laminin binding | 5.79e-04 | 34 | 21 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | fibronectin binding | 7.24e-04 | 38 | 21 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 8.43e-04 | 41 | 21 | 2 | GO:0000217 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 2.65e-03 | 73 | 21 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | lipid binding | 3.08e-03 | 988 | 21 | 5 | GO:0008289 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.57e-03 | 85 | 21 | 2 | GO:0038024 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 2.96e-06 | 3 | 21 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 5.92e-06 | 4 | 21 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 7.50e-06 | 38 | 21 | 3 | GO:0030517 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 9.85e-06 | 5 | 21 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | developmental growth | 2.16e-05 | 911 | 21 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 2.18e-05 | 54 | 21 | 3 | GO:0050922 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 3.31e-05 | 62 | 21 | 3 | GO:0050771 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 4.42e-05 | 10 | 21 | 2 | GO:0022028 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 5.16e-05 | 207 | 21 | 4 | GO:1990138 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 5.40e-05 | 11 | 21 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 7.65e-05 | 13 | 21 | 2 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 7.65e-05 | 13 | 21 | 2 | GO:0021843 | |
| GeneOntologyBiologicalProcess | growth | 1.50e-04 | 1235 | 21 | 7 | GO:0040007 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 1.55e-04 | 104 | 21 | 3 | GO:0030516 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 2.13e-04 | 299 | 21 | 4 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 2.19e-04 | 301 | 21 | 4 | GO:0048588 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 2.25e-04 | 22 | 21 | 2 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 2.25e-04 | 22 | 21 | 2 | GO:1902284 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 2.48e-04 | 122 | 21 | 3 | GO:0061387 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 2.69e-04 | 24 | 21 | 2 | GO:0031290 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental growth | 2.73e-04 | 126 | 21 | 3 | GO:0048640 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron differentiation | 3.16e-04 | 26 | 21 | 2 | GO:0021889 | |
| GeneOntologyBiologicalProcess | axon extension | 3.35e-04 | 135 | 21 | 3 | GO:0048675 | |
| GeneOntologyBiologicalProcess | circulatory system development | 3.91e-04 | 1442 | 21 | 7 | GO:0072359 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 3.94e-04 | 29 | 21 | 2 | GO:0003417 | |
| GeneOntologyBiologicalProcess | neuron development | 4.27e-04 | 1463 | 21 | 7 | GO:0048666 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 4.38e-04 | 148 | 21 | 3 | GO:0006986 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 4.55e-04 | 150 | 21 | 3 | GO:0090288 | |
| GeneOntologyBiologicalProcess | kidney development | 4.89e-04 | 372 | 21 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 5.62e-04 | 386 | 21 | 4 | GO:0072001 | |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 5.76e-04 | 35 | 21 | 2 | GO:0008045 | |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 6.12e-04 | 166 | 21 | 3 | GO:0035966 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 6.45e-04 | 169 | 21 | 3 | GO:0010977 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 6.90e-04 | 173 | 21 | 3 | GO:0050768 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 6.94e-04 | 1125 | 21 | 6 | GO:0035239 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 7.15e-04 | 39 | 21 | 2 | GO:0003416 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 7.52e-04 | 40 | 21 | 2 | GO:0097242 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 7.77e-04 | 421 | 21 | 4 | GO:0048638 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 7.90e-04 | 41 | 21 | 2 | GO:1901889 | |
| GeneOntologyBiologicalProcess | heart development | 8.19e-04 | 757 | 21 | 5 | GO:0007507 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 8.25e-04 | 184 | 21 | 3 | GO:0051961 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 9.33e-04 | 192 | 21 | 3 | GO:0050770 | |
| GeneOntologyBiologicalProcess | bone growth | 9.52e-04 | 45 | 21 | 2 | GO:0098868 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium assembly | 9.52e-04 | 45 | 21 | 2 | GO:0010591 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.04e-03 | 47 | 21 | 2 | GO:0060351 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.06e-03 | 802 | 21 | 5 | GO:0048812 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.08e-03 | 48 | 21 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.15e-03 | 817 | 21 | 5 | GO:0048514 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.17e-03 | 819 | 21 | 5 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.21e-03 | 826 | 21 | 5 | GO:0048858 | |
| GeneOntologyBiologicalProcess | endocytosis | 1.22e-03 | 827 | 21 | 5 | GO:0006897 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 1.22e-03 | 51 | 21 | 2 | GO:0050919 | |
| GeneOntologyBiologicalProcess | negative regulation of cell growth | 1.24e-03 | 212 | 21 | 3 | GO:0030308 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.30e-03 | 1269 | 21 | 6 | GO:0009887 | |
| GeneOntologyBiologicalProcess | olfactory bulb development | 1.32e-03 | 53 | 21 | 2 | GO:0021772 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 1.42e-03 | 55 | 21 | 2 | GO:0035886 | |
| GeneOntologyBiologicalProcess | olfactory lobe development | 1.47e-03 | 56 | 21 | 2 | GO:0021988 | |
| GeneOntologyBiologicalProcess | regulation of cell size | 1.47e-03 | 225 | 21 | 3 | GO:0008361 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium organization | 1.52e-03 | 57 | 21 | 2 | GO:1902743 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 1.63e-03 | 233 | 21 | 3 | GO:0031345 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.64e-03 | 515 | 21 | 4 | GO:0050767 | |
| GeneOntologyBiologicalProcess | chemotaxis | 1.66e-03 | 517 | 21 | 4 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 1.69e-03 | 519 | 21 | 4 | GO:0042330 | |
| GeneOntologyBiologicalProcess | regulation of chemotaxis | 1.81e-03 | 242 | 21 | 3 | GO:0050920 | |
| GeneOntologyBiologicalProcess | neutral lipid biosynthetic process | 1.86e-03 | 63 | 21 | 2 | GO:0046460 | |
| GeneOntologyBiologicalProcess | acylglycerol biosynthetic process | 1.86e-03 | 63 | 21 | 2 | GO:0046463 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte chemotaxis | 1.98e-03 | 65 | 21 | 2 | GO:0071622 | |
| GeneOntologyBiologicalProcess | blood vessel development | 2.04e-03 | 929 | 21 | 5 | GO:0001568 | |
| GeneOntologyBiologicalProcess | tube development | 2.18e-03 | 1402 | 21 | 6 | GO:0035295 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 2.22e-03 | 69 | 21 | 2 | GO:0006911 | |
| GeneOntologyBiologicalProcess | blood coagulation | 2.23e-03 | 260 | 21 | 3 | GO:0007596 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.29e-03 | 70 | 21 | 2 | GO:1900047 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.32e-03 | 566 | 21 | 4 | GO:0007409 | |
| GeneOntologyBiologicalProcess | coagulation | 2.38e-03 | 266 | 21 | 3 | GO:0050817 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 2.42e-03 | 72 | 21 | 2 | GO:0022029 | |
| GeneOntologyBiologicalProcess | hemostasis | 2.43e-03 | 268 | 21 | 3 | GO:0007599 | |
| GeneOntologyBiologicalProcess | vasculature development | 2.46e-03 | 969 | 21 | 5 | GO:0001944 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 2.62e-03 | 75 | 21 | 2 | GO:0021885 | |
| GeneOntologyBiologicalProcess | epithelium development | 2.76e-03 | 1469 | 21 | 6 | GO:0060429 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 2.83e-03 | 78 | 21 | 2 | GO:0099024 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 2.83e-03 | 283 | 21 | 3 | GO:0045926 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.89e-03 | 285 | 21 | 3 | GO:0007411 | |
| GeneOntologyCellularComponent | cell surface | 6.05e-04 | 1111 | 21 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.73e-03 | 530 | 21 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.76e-03 | 656 | 21 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.80e-03 | 658 | 21 | 4 | GO:0030312 | |
| GeneOntologyCellularComponent | secretory granule lumen | 4.02e-03 | 325 | 21 | 3 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 4.20e-03 | 330 | 21 | 3 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 4.27e-03 | 332 | 21 | 3 | GO:0031983 | |
| Domain | EGF_CA | 4.98e-13 | 122 | 21 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.69e-13 | 124 | 21 | 8 | IPR001881 | |
| Domain | EGF_Ca-bd_CS | 8.96e-12 | 97 | 21 | 7 | IPR018097 | |
| Domain | EGF_CA | 1.04e-11 | 99 | 21 | 7 | PS01187 | |
| Domain | EGF_3 | 9.85e-11 | 235 | 21 | 8 | PS50026 | |
| Domain | EGF | 9.85e-11 | 235 | 21 | 8 | SM00181 | |
| Domain | EGF-like_dom | 1.56e-10 | 249 | 21 | 8 | IPR000742 | |
| Domain | EGF-like_CS | 2.27e-10 | 261 | 21 | 8 | IPR013032 | |
| Domain | EGF_2 | 2.56e-10 | 265 | 21 | 8 | PS01186 | |
| Domain | EGF_CA | 4.10e-10 | 86 | 21 | 6 | PF07645 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.47e-09 | 106 | 21 | 6 | IPR000152 | |
| Domain | EGF_1 | 8.05e-09 | 255 | 21 | 7 | PS00022 | |
| Domain | Growth_fac_rcpt_ | 1.51e-08 | 156 | 21 | 6 | IPR009030 | |
| Domain | cEGF | 1.74e-08 | 26 | 21 | 4 | IPR026823 | |
| Domain | cEGF | 1.74e-08 | 26 | 21 | 4 | PF12662 | |
| Domain | ASX_HYDROXYL | 7.56e-08 | 100 | 21 | 5 | PS00010 | |
| Domain | EGF | 2.41e-07 | 126 | 21 | 5 | PF00008 | |
| Domain | Ldl_recept_b | 4.42e-07 | 14 | 21 | 3 | PF00058 | |
| Domain | LDLRB | 4.42e-07 | 14 | 21 | 3 | PS51120 | |
| Domain | LY | 5.53e-07 | 15 | 21 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.53e-07 | 15 | 21 | 3 | IPR000033 | |
| Domain | - | 3.52e-06 | 95 | 21 | 4 | 2.60.120.200 | |
| Domain | - | 1.09e-05 | 39 | 21 | 3 | 2.120.10.30 | |
| Domain | TSP3 | 1.20e-05 | 5 | 21 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.20e-05 | 5 | 21 | 2 | PS51236 | |
| Domain | - | 1.20e-05 | 5 | 21 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.20e-05 | 5 | 21 | 2 | IPR008859 | |
| Domain | TSP_C | 1.20e-05 | 5 | 21 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.20e-05 | 5 | 21 | 2 | IPR017897 | |
| Domain | TSP_3 | 1.20e-05 | 5 | 21 | 2 | PF02412 | |
| Domain | Thrombospondin_3-like_rpt | 1.20e-05 | 5 | 21 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 1.20e-05 | 5 | 21 | 2 | IPR028974 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.80e-05 | 46 | 21 | 3 | IPR011042 | |
| Domain | Laminin_G | 3.63e-05 | 58 | 21 | 3 | IPR001791 | |
| Domain | Fol_N | 6.58e-05 | 11 | 21 | 2 | IPR003645 | |
| Domain | FOLN | 6.58e-05 | 11 | 21 | 2 | SM00274 | |
| Domain | EGF_3 | 7.89e-05 | 12 | 21 | 2 | PF12947 | |
| Domain | EGF_dom | 7.89e-05 | 12 | 21 | 2 | IPR024731 | |
| Domain | ConA-like_dom | 9.41e-05 | 219 | 21 | 4 | IPR013320 | |
| Domain | CTCK_1 | 1.82e-04 | 18 | 21 | 2 | PS01185 | |
| Domain | CT | 2.74e-04 | 22 | 21 | 2 | SM00041 | |
| Domain | Cys_knot_C | 3.56e-04 | 25 | 21 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.56e-04 | 25 | 21 | 2 | PS01225 | |
| Domain | hEGF | 4.47e-04 | 28 | 21 | 2 | PF12661 | |
| Domain | LRRCT | 5.85e-04 | 32 | 21 | 2 | PF01463 | |
| Domain | LAM_G_DOMAIN | 8.26e-04 | 38 | 21 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 9.15e-04 | 40 | 21 | 2 | PF02210 | |
| Domain | LDLR_class-A_CS | 9.15e-04 | 40 | 21 | 2 | IPR023415 | |
| Domain | LamG | 1.11e-03 | 44 | 21 | 2 | SM00282 | |
| Domain | Ldl_recept_a | 1.16e-03 | 45 | 21 | 2 | PF00057 | |
| Domain | - | 1.21e-03 | 46 | 21 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.32e-03 | 48 | 21 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.37e-03 | 49 | 21 | 2 | IPR002172 | |
| Domain | LDLa | 1.37e-03 | 49 | 21 | 2 | SM00192 | |
| Domain | LDLRA_2 | 1.37e-03 | 49 | 21 | 2 | PS50068 | |
| Domain | LRRNT | 1.60e-03 | 53 | 21 | 2 | PF01462 | |
| Domain | EGF_extracell | 2.05e-03 | 60 | 21 | 2 | IPR013111 | |
| Domain | EGF_2 | 2.05e-03 | 60 | 21 | 2 | PF07974 | |
| Domain | Cys-rich_flank_reg_C | 4.54e-03 | 90 | 21 | 2 | IPR000483 | |
| Domain | LRRCT | 4.54e-03 | 90 | 21 | 2 | SM00082 | |
| Domain | LRRNT | 5.36e-03 | 98 | 21 | 2 | IPR000372 | |
| Domain | LRRNT | 5.36e-03 | 98 | 21 | 2 | SM00013 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 7.70e-05 | 10 | 19 | 2 | M27348 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.74e-04 | 96 | 19 | 3 | M39581 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.42e-04 | 258 | 19 | 4 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.05e-04 | 300 | 19 | 4 | M610 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.28e-07 | 248 | 21 | 5 | 24006456 | |
| Pubmed | Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment. | 3.47e-07 | 2 | 21 | 2 | 22264230 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 12515855 | ||
| Pubmed | Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis. | 3.47e-07 | 2 | 21 | 2 | 24330664 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 23320558 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 3.47e-07 | 2 | 21 | 2 | 12097499 | |
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 3.47e-07 | 2 | 21 | 2 | 12200164 | |
| Pubmed | Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix. | 3.47e-07 | 2 | 21 | 2 | 25995382 | |
| Pubmed | COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations. | 3.47e-07 | 2 | 21 | 2 | 24187101 | |
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 3.47e-07 | 2 | 21 | 2 | 10432110 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 6.15e-07 | 28 | 21 | 3 | 27002738 | |
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 1.04e-06 | 3 | 21 | 2 | 16162649 | |
| Pubmed | Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region. | 1.04e-06 | 3 | 21 | 2 | 18285447 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 9813312 | ||
| Pubmed | A molecular mechanism for the heparan sulfate dependence of slit-robo signaling. | 1.04e-06 | 3 | 21 | 2 | 17062560 | |
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 1.04e-06 | 3 | 21 | 2 | 12141424 | |
| Pubmed | New neurons follow the flow of cerebrospinal fluid in the adult brain. | 1.04e-06 | 3 | 21 | 2 | 16410488 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 10364234 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 1.04e-06 | 3 | 21 | 2 | 24065825 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16840550 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 25712208 | ||
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 1.04e-06 | 3 | 21 | 2 | 26168731 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 7775583 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 10433822 | ||
| Pubmed | Multiple roles for slits in the control of cell migration in the rostral migratory stream. | 2.08e-06 | 4 | 21 | 2 | 14960623 | |
| Pubmed | Contralateral migration of oculomotor neurons is regulated by Slit/Robo signaling. | 2.08e-06 | 4 | 21 | 2 | 27770832 | |
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 2.08e-06 | 4 | 21 | 2 | 16828733 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 30622267 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 12609596 | ||
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 3.47e-06 | 5 | 21 | 2 | 15207848 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 18467703 | ||
| Pubmed | Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization. | 3.47e-06 | 5 | 21 | 2 | 25894826 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 28234971 | ||
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 3.47e-06 | 5 | 21 | 2 | 12954717 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 11520671 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 22000108 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 16885222 | ||
| Pubmed | Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals. | 3.47e-06 | 5 | 21 | 2 | 21118670 | |
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 3.47e-06 | 5 | 21 | 2 | 11748139 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 11804570 | ||
| Pubmed | SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. | 5.20e-06 | 6 | 21 | 2 | 18829537 | |
| Pubmed | Slit antagonizes netrin-1 attractive effects during the migration of inferior olivary neurons. | 5.20e-06 | 6 | 21 | 2 | 12051827 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 18054781 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 10864954 | ||
| Pubmed | Robo1 and robo2 control the development of the lateral olfactory tract. | 5.20e-06 | 6 | 21 | 2 | 17360927 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 16439476 | ||
| Pubmed | Pioneer longitudinal axons navigate using floor plate and Slit/Robo signals. | 5.20e-06 | 6 | 21 | 2 | 18842816 | |
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 5.20e-06 | 6 | 21 | 2 | 34249921 | |
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 5.20e-06 | 6 | 21 | 2 | 22306607 | |
| Pubmed | Slit/Robo-mediated chemorepulsion of vagal sensory axons in the fetal gut. | 5.20e-06 | 6 | 21 | 2 | 23161783 | |
| Pubmed | 6.82e-06 | 1285 | 21 | 7 | 35914814 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 20606719 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 28676569 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 21688288 | ||
| Pubmed | Slit molecules prevent entrance of trunk neural crest cells in developing gut. | 7.28e-06 | 7 | 21 | 2 | 25490618 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 7.90e-06 | 475 | 21 | 5 | 31040226 | |
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 23884932 | ||
| Pubmed | Robos and slits control the pathfinding and targeting of mouse olfactory sensory axons. | 9.70e-06 | 8 | 21 | 2 | 18417704 | |
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 17581972 | ||
| Pubmed | Conserved roles for Slit and Robo proteins in midline commissural axon guidance. | 9.70e-06 | 8 | 21 | 2 | 15091338 | |
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 9.70e-06 | 8 | 21 | 2 | 24460873 | |
| Pubmed | Multiple Slits regulate the development of midline glial populations and the corpus callosum. | 9.70e-06 | 8 | 21 | 2 | 22349628 | |
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 16774856 | ||
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 15162513 | ||
| Pubmed | Motor axons are guided to exit points in the spinal cord by Slit and Netrin signals. | 9.70e-06 | 8 | 21 | 2 | 28986144 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 9.70e-06 | 8 | 21 | 2 | 25485759 | |
| Pubmed | Robo1 and Robo2 cooperate to control the guidance of major axonal tracts in the mammalian forebrain. | 9.70e-06 | 8 | 21 | 2 | 17392456 | |
| Pubmed | Slit2 and Robo3 modulate the migration of GnRH-secreting neurons. | 9.70e-06 | 8 | 21 | 2 | 22912413 | |
| Pubmed | 1.06e-05 | 71 | 21 | 3 | 33541421 | ||
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 1.25e-05 | 9 | 21 | 2 | 10772929 | |
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 10864955 | ||
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 25056828 | ||
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 22806432 | ||
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 1.25e-05 | 9 | 21 | 2 | 20631173 | |
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 21307234 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 31356769 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 26627825 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 12642493 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.81e-05 | 564 | 21 | 5 | 21565611 | |
| Pubmed | 1.90e-05 | 11 | 21 | 2 | 11804571 | ||
| Pubmed | 1.90e-05 | 11 | 21 | 2 | 22399681 | ||
| Pubmed | Knockdown of slit signaling during limb development leads to a reduction in humerus length. | 1.90e-05 | 11 | 21 | 2 | 33347679 | |
| Pubmed | 1.90e-05 | 11 | 21 | 2 | 24639464 | ||
| Pubmed | 1.90e-05 | 11 | 21 | 2 | 26520399 | ||
| Pubmed | Molecular mechanisms controlling midline crossing by precerebellar neurons. | 1.90e-05 | 11 | 21 | 2 | 18562598 | |
| Pubmed | 2.28e-05 | 12 | 21 | 2 | 22981605 | ||
| Pubmed | Robo2 is required for Slit-mediated intraretinal axon guidance. | 2.28e-05 | 12 | 21 | 2 | 19782674 | |
| Pubmed | Roundabout receptors are critical for foregut separation from the body wall. | 2.28e-05 | 12 | 21 | 2 | 23328398 | |
| Pubmed | Sim1 and Sim2 are required for the correct targeting of mammillary body axons. | 2.28e-05 | 12 | 21 | 2 | 16291793 | |
| Pubmed | 2.28e-05 | 12 | 21 | 2 | 16540508 | ||
| Pubmed | Dual role for LIM-homeodomain gene Lhx2 in the formation of the lateral olfactory tract. | 2.28e-05 | 12 | 21 | 2 | 17329426 | |
| Pubmed | 2.28e-05 | 12 | 21 | 2 | 11830575 | ||
| Pubmed | 2.28e-05 | 12 | 21 | 2 | 19906969 | ||
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 2.70e-05 | 13 | 21 | 2 | 23534961 | |
| Pubmed | Expression of Slit and Robo genes in the developing mouse heart. | 2.70e-05 | 13 | 21 | 2 | 20941780 | |
| Pubmed | 2.70e-05 | 13 | 21 | 2 | 25366972 | ||
| Pubmed | 2.70e-05 | 13 | 21 | 2 | 19700621 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 2.95e-05 | 100 | 21 | 3 | 25807483 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.04e-05 | 101 | 21 | 3 | 20551380 | |
| Pubmed | 3.15e-05 | 14 | 21 | 2 | 15082773 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 6.55e-04 | 377 | 21 | 3 | chr21q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 2.05e-03 | 147 | 21 | 2 | chr15q15 | |
| GeneFamily | Low density lipoprotein receptors | 2.14e-05 | 13 | 10 | 2 | 634 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.61e-07 | 191 | 21 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.10e-07 | 196 | 21 | 5 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.99e-06 | 270 | 21 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.17e-06 | 275 | 21 | 5 | M5884 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.78e-05 | 200 | 21 | 4 | M5930 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN | 1.78e-05 | 200 | 21 | 4 | M7878 | |
| Coexpression | NABA_MATRISOME | 1.05e-04 | 1008 | 21 | 6 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.16e-04 | 1026 | 21 | 6 | M5889 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 1.20e-04 | 121 | 21 | 3 | M12828 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 1.22e-04 | 1035 | 21 | 6 | M9898 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 1.35e-04 | 650 | 21 | 5 | M8448 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 1.55e-04 | 132 | 21 | 3 | MM465 | |
| Coexpression | HALLMARK_COAGULATION | 1.77e-04 | 138 | 21 | 3 | M5946 | |
| Coexpression | SCHOEN_NFKB_SIGNALING | 3.38e-04 | 34 | 21 | 2 | M1983 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 3.67e-04 | 438 | 21 | 4 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 3.74e-04 | 440 | 21 | 4 | MM832 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 3.74e-04 | 178 | 21 | 3 | M17079 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 3.90e-04 | 445 | 21 | 4 | M3645 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS | 4.00e-04 | 37 | 21 | 2 | M40310 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 4.22e-04 | 38 | 21 | 2 | M47982 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN | 5.18e-04 | 199 | 21 | 3 | M4142 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN | 5.18e-04 | 199 | 21 | 3 | M5151 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_UP | 5.26e-04 | 200 | 21 | 3 | M3396 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 5.26e-04 | 200 | 21 | 3 | M9341 | |
| Coexpression | GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M8518 | |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN | 5.26e-04 | 200 | 21 | 3 | M4463 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN | 5.26e-04 | 200 | 21 | 3 | M6018 | |
| Coexpression | PARK_HSC_AND_MULTIPOTENT_PROGENITORS | 5.93e-04 | 45 | 21 | 2 | M1456 | |
| Coexpression | DAUER_STAT3_TARGETS_UP | 6.74e-04 | 48 | 21 | 2 | M12391 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 2.73e-06 | 1370 | 21 | 9 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 3.55e-06 | 1414 | 21 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K1 | 4.06e-06 | 32 | 21 | 3 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K1 | 4.56e-05 | 71 | 21 | 3 | facebase_RNAseq_e9.5_MaxArch_2500_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.81e-05 | 1094 | 21 | 7 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K0 | 1.59e-04 | 108 | 21 | 3 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | 2.15e-04 | 1347 | 21 | 7 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 2.94e-04 | 986 | 21 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.08e-04 | 339 | 21 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | 3.10e-04 | 1429 | 21 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.36e-07 | 158 | 21 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.36e-07 | 158 | 21 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-06 | 167 | 21 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-06 | 167 | 21 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.17e-06 | 172 | 21 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.74e-06 | 190 | 21 | 4 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-06 | 192 | 21 | 4 | 11867f30f0b420c18cb0b34d3990237aa737a0e8 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.86e-06 | 193 | 21 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 194 | 21 | 4 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 196 | 21 | 4 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 196 | 21 | 4 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.10e-06 | 199 | 21 | 4 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 199 | 21 | 4 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 199 | 21 | 4 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.10e-06 | 199 | 21 | 4 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.10e-06 | 199 | 21 | 4 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.10e-06 | 199 | 21 | 4 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.10e-06 | 199 | 21 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 2.10e-06 | 199 | 21 | 4 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.10e-06 | 199 | 21 | 4 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-05 | 128 | 21 | 3 | 376102331d79010c1b2ce26e6ab0134c7b8a4ec3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-05 | 151 | 21 | 3 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.81e-05 | 162 | 21 | 3 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-05 | 166 | 21 | 3 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 167 | 21 | 3 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 167 | 21 | 3 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-05 | 168 | 21 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.47e-05 | 168 | 21 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.59e-05 | 169 | 21 | 3 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.59e-05 | 169 | 21 | 3 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-05 | 171 | 21 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.82e-05 | 171 | 21 | 3 | 3ad4f138d9570500cfb4423a2be16bb7d1cacbf8 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.82e-05 | 171 | 21 | 3 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.82e-05 | 171 | 21 | 3 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 173 | 21 | 3 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.06e-05 | 173 | 21 | 3 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.06e-05 | 173 | 21 | 3 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 173 | 21 | 3 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 173 | 21 | 3 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.31e-05 | 175 | 21 | 3 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.31e-05 | 175 | 21 | 3 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 7.43e-05 | 176 | 21 | 3 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.43e-05 | 176 | 21 | 3 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 7.43e-05 | 176 | 21 | 3 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-05 | 176 | 21 | 3 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-05 | 176 | 21 | 3 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.56e-05 | 177 | 21 | 3 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.56e-05 | 177 | 21 | 3 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-05 | 178 | 21 | 3 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.68e-05 | 178 | 21 | 3 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-05 | 178 | 21 | 3 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.81e-05 | 179 | 21 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 180 | 21 | 3 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.07e-05 | 181 | 21 | 3 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.07e-05 | 181 | 21 | 3 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 184 | 21 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 184 | 21 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 184 | 21 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 184 | 21 | 3 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 8.48e-05 | 184 | 21 | 3 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-05 | 185 | 21 | 3 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-05 | 185 | 21 | 3 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.75e-05 | 186 | 21 | 3 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.03e-05 | 188 | 21 | 3 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.03e-05 | 188 | 21 | 3 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 9.18e-05 | 189 | 21 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 190 | 21 | 3 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.32e-05 | 190 | 21 | 3 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.32e-05 | 190 | 21 | 3 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 190 | 21 | 3 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 190 | 21 | 3 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-05 | 191 | 21 | 3 | 054e9a79bd1486fd812bc7418fb091664fe3a646 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 191 | 21 | 3 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 192 | 21 | 3 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.62e-05 | 192 | 21 | 3 | 9479e9859140ba98abfe88414de0b28fc2bf43b7 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 192 | 21 | 3 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.62e-05 | 192 | 21 | 3 | d7faa993f68e530ad55185505384ae155d36c222 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.62e-05 | 192 | 21 | 3 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 9.62e-05 | 192 | 21 | 3 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 192 | 21 | 3 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.62e-05 | 192 | 21 | 3 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 192 | 21 | 3 | 8b625c22dda23c99654c82c529a1233e99e71b54 | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.62e-05 | 192 | 21 | 3 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 192 | 21 | 3 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.76e-05 | 193 | 21 | 3 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.76e-05 | 193 | 21 | 3 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.91e-05 | 194 | 21 | 3 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 9.91e-05 | 194 | 21 | 3 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 9.91e-05 | 194 | 21 | 3 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 9.91e-05 | 194 | 21 | 3 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.91e-05 | 194 | 21 | 3 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 195 | 21 | 3 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 195 | 21 | 3 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.01e-04 | 195 | 21 | 3 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.01e-04 | 195 | 21 | 3 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 196 | 21 | 3 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 196 | 21 | 3 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 196 | 21 | 3 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 196 | 21 | 3 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 196 | 21 | 3 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A | 2.84e-05 | 196 | 21 | 4 | 2390_DN | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; HL60; HT_HG-U133A | 2.84e-05 | 196 | 21 | 4 | 6133_UP | |
| Drug | vinylidene chloride | 2.89e-05 | 1475 | 21 | 8 | ctd:C029297 | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.96e-05 | 198 | 21 | 4 | 3419_UP | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.08e-05 | 200 | 21 | 4 | 1674_UP | |
| Drug | 2-(3-guanidinophenyl)-2-[[1-(hydrocinnamoylamino)-2-methyl-propyl]-hydroxy-phosphoryl]oxy-acetic acid | 6.28e-05 | 13 | 21 | 2 | CID010310938 | |
| Drug | diethyl malate | 6.59e-05 | 86 | 21 | 3 | ctd:C058705 | |
| Drug | pyrachlostrobin | 6.88e-05 | 811 | 21 | 6 | ctd:C513428 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.16e-05 | 10 | 21 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | functional brain measurement, language measurement | 1.80e-04 | 28 | 21 | 2 | EFO_0007797, EFO_0007849 | |
| Disease | pack-years measurement, systolic blood pressure | 2.67e-04 | 34 | 21 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 3.16e-04 | 37 | 21 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | optic disc size measurement | 4.01e-04 | 205 | 21 | 3 | EFO_0004832 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 4.69e-04 | 45 | 21 | 2 | DOID:8947 (biomarker_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.56e-04 | 49 | 21 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | COVID-19 (is_marker_for) | 9.18e-04 | 63 | 21 | 2 | DOID:0080600 (is_marker_for) | |
| Disease | rheumatoid arthritis (is_marker_for) | 1.10e-03 | 69 | 21 | 2 | DOID:7148 (is_marker_for) | |
| Disease | migraine disorder, endometriosis | 1.23e-03 | 73 | 21 | 2 | EFO_0001065, MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QNQDEDCNEKNGCHE | 771 | Q9P2K8 | |
| DACDNCRSQKNDDQK | 346 | P49747 | |
| ECQDEENQKQCQDLG | 1636 | P01024 | |
| NQNIDCADASDEKNC | 2611 | Q9NZR2 | |
| CTNCYNNLEHENERQ | 551 | Q6MZP7 | |
| CSSHEEENRCNFNQQ | 11 | Q8TDD5 | |
| CDCDVHKHNQNENLV | 1081 | Q8IYD8 | |
| QHVKAECSQCSNNES | 791 | Q14149 | |
| DEDKRHQCQNQNCSD | 2936 | P98164 | |
| NAANKETCEHNHRQC | 481 | Q14112 | |
| SDDHCQREQELQKEN | 2051 | O15078 | |
| VEKENNCHSAENNSN | 176 | Q56NI9 | |
| DGHNCLDVDECQDNN | 111 | Q8IWY4 | |
| AKNCDNKNEQLQCDH | 241 | Q9P212 | |
| NKNEQLQCDHCDTLN | 246 | Q9P212 | |
| VHCEQLDAQNQQRCE | 966 | O60287 | |
| CDNNQDIDEDGHQNN | 856 | P07996 | |
| SNRNDEHCGNSNNKC | 1431 | P53804 | |
| DFDDCQDNKCKNGAH | 1076 | O94813 | |
| AHQQECCQKFEQLSE | 341 | Q9Y5X3 | |
| SENQDDCRDHRCQNG | 1081 | O75093 | |
| SQQCQENHDNGNHTC | 1286 | Q6PFW1 |